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Abstract
The molecular regulatory mechanisms and the characterization of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in hypoxia were
studied in a mouse brain capillary endothelial cell line, MBEC4. Activation of GAPDH gene expression by hypoxia was suppressed by an
intracellular Ca2 + chelator and inhibited by a non-selective cation channel blocker or a Na+/Ca2 + exchanger (NCX) blocker. Sequencing of
reverse transcription-PCR products demonstrated that MBEC4 expressed an mRNA encoding NCX3, which functions even under cellular
ATP-depleted conditions, in addition to mRNAs encoding NCX1 and NCX2. The inhibition of Ca2 +/calmodulin-dependent protein kinases
or c-Jun/AP-1 activation caused a significant decrease in the activation of GAPDH mRNA by hypoxia. These results suggest that hypoxia
stimulates Ca2 + influx through non-selective cation channels and causes the reverse operation of the three NCX isoforms, and consequently,
increased intracellular Ca2 + up-regulates GAPDH gene expression through an AP-1-dependent pathway. Furthermore, subcellular
fractionation experiments showed that hypoxia increased GAPDH proteins not only in the cytosolic fraction, but also in the nuclear and
particulate fractions, in which GAPDH should play no roles in glycolysis. However, the GAPDH activity did not rise in proportion to the
increase of GAPDH protein by hypoxia even in the cytosolic fraction. These results suggest that not all hypoxia-induced GAPDH molecules
contribute to glycolysis.
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1. Introduction
Molecular oxygen is an essential factor for survival in
mammals because it is available as an electron acceptor for
ATP production in oxidative phosphorylation. Mammals
possess genetic programs that respond to alterations in
intracellular oxygen tension in a tissue-specific fashion.
Insufficient supply of oxygen to body tissues stimulates
both erythropoiesis and angiogenesis by up-regulating the
production of erythropoietin and vascular endothelial
growth factor (VEGF) [1,2]. Furthermore, mammalian cells
enhance the rate of glucose utilization by up-regulating the
expression of genes involved in glycolysis and glucose
transport to compensate for a decrease in ATP production
when deprived of oxygen [3–6]. Most of these hypoxia-
induced genes are transactivated by hypoxia-inducible fac-
tor-1 (HIF-1), which interacts with the enhancer sequence
termed hypoxia-response element [7,8].
Endothelial cells are located inside blood vessels, which
play a pivotal role in transporting oxygen to all tissues, and
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initially sense an alteration in blood oxygen tension.
Because vascular endothelial cells can remain viable during
prolonged hypoxic exposure much better than nonendothe-
lial cells such as fibroblasts, smooth muscle cells, and renal
tubular cells [9], endothelial cells are presumed to be one of
the mammalian cell types with a higher hypoxia tolerance.
Chinese hamster ovary cells, and myocardiac and brain
tissues express heat shock proteins in response to hypoxia
[10–12]. In contrast, endothelial cells up-regulate some
hypoxia-specific and unique proteins, termed hypoxia-asso-
ciated proteins (HAPs), which are different from heat shock
proteins [13,14]. Furthermore, exposure of endothelial cells
to sodium cyanide, which irreversibly blocks oxidative
phosphorylation and is used as a form of chemical hypoxia,
causes no induction of any specific proteins [9], indicating
that environmental hypoxia is necessary to up-regulate the
expression of HAPs in endothelial cells. Graven et al. [15]
found that glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was a HAP. GAPDH is one of the glycolytic
enzymes for energy production in the cytosolic fraction and
is composed of a tetramer of identical 36 kDa subunits. It
catalyzes the reversible oxidation of D-glyceraldehyde-3-
phosphate to 1,3-diphosphoglycerate. In addition, GAPDH
has a variety of diverse biological properties such as DNA
repair and replication, translational regulation and endocy-
tosis in the nuclear and membrane fractions [16–19].
HIF-1 binding is necessary, but not sufficient, for the
induction of GAPDH gene expression in endothelial cells
[20]. Previous studies have shown that hypoxia causes an
increase in intracellular Ca2 + concentration. Some studies
have represented that the increase is due to Ca2 + release from
the internal store [21–23]. The others have demonstrated that
the source of increased Ca2 + is derived from the extracellular
space [24–27]. The release of Ca2 + from the internal store is
needed to activate the transcription of VEGF gene in 293
cells (an adenovirus-transformed human fetal kidney cell
line) exposed to hypoxia [22]. In contrast, hypoxia accel-
erates Ca2 + influx from the extracellular space through L-
type Ca2 + channels in PC12 cells (a rat pheochromocytoma
cell line), followed by the up-regulation of tyrosine hydrox-
ylase gene expression [24]. Here we report that the level of
hypoxia-induced GAPDHmRNA is inhibited by chelation of
intracellular Ca2 + in MBEC4 cells, a mouse brain capillary
endothelial cell line [27], and analyze Ca2 + channels and
transcriptional factors involved in hypoxia-stimulated
GAPDH gene expression. Furthermore, we determined the
protein and activity levels of GAPDH in subcellular fractions
under normoxic and hypoxic conditions.
2. Materials and methods
2.1. Materials
The following chemicals and reagents were used:
AlkPhos Direct with CDP-star and Hybond-N+ membrane
from Amersham Pharmacia Biotech, RNAzol from Tel-Test
(TX, USA), oligotex-dT30 hsuperi kit from Roche Diag-
nostics, Dulbecco’s modified Eagle’s medium from Nissui
Pharmaceutical (Tokyo, Japan), fetal calf serum, penicillin/
streptomycin and reverse transcriptase (Superscript II
RNase H) from GIBCO, 1,2-bis(o-aminophenoxy)ethane-
N,N,NV,NV-tetraacetic acid tetra(acetoxymethyl) ester
(BAPTA-AM) from Dojindo (Kumamoto, Japan), KN-93
from Calbiochem (Darmstadt, Germany), bepridil hydro-
chloride, curcumin and LaCl3 from Nacalai Tesque (Kyoto,
Japan), anti-lamin B1 antibody from Zymed Laboratories
(CA, USA), and nifedipine and verapamil hydrochloride
from Wako Pure Chemical Industries (Osaka, Japan). Stock
solutions of BAPTA-AM, KN-93 and nifedipine were made
in dimethyl sulphoxide and curcumin was dissolved in
ethanol.
2.2. Cell culture and viability
MBEC4 cells were cultured in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal calf serum,
100 U/ml penicillin and 100 Ag/ml streptomycin, as
described previously [28] and maintained at 37jC in a 5%
CO2/95% air atmosphere at 100% humidity unless other-
wise indicated. Cell viability was based on the ability of
cells to exclude trypan blue.
2.3. Exposure to pharmacological reagents
MBEC4 cells that had reached approximately 80% con-
fluence were exposed to normoxia (5% CO2/95% air atmos-
phere) or hypoxia (5% CO2 and 2% O2 balanced with N2:
ESPEC, Model BNP-110 M) for 6 h in the presence or
absence of BAPTA-AM, LaCl3, nifedipine, verapamil,
bepridil, KN-93 or curcumin. The medium was renewed
24 h before the hypoxic exposure. BAPTA-AM, LaCl3,
bepridil, nifedipine, verapamil, KN-93 or curcumin was
added to the medium 1 h before the exposure.
2.4. Northern blot analysis
Total RNA was prepared from MBEC4 cells using
RNAzol, and 20 Ag of the RNA was separated by electro-
phoresis through 1% agarose gel containing 2.2 M form-
aldehyde, and transferred to a Hybond-N+ membrane in
20 SSC (1 : 15 mM sodium citrate and 150 mM sodium
chloride, pH 7.0). The membrane was cross-linked with UV
light. GPDN5 plasmid containing rat GAPDH cDNA was
kindly donated by Dr. Fort (Universite´ Montpellier I-Uni-
versite´ Montpellier II, France) and pHr14E3 containing
human 28S ribosomal DNAwas obtained from the Japanese
Cancer Research Resources Bank (Tokyo, Japan). KpnI-
digested GPDN5 and BamHI-digested pHr14E were labeled
with alkaline phosphatase using AlkPhos Direct according
to the manufacturer’s instructions, and used as probes for
detection of GAPDH and 28S rRNA, respectively. Hybrid-
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ization was performed at 55jC, and chemiluminescence
signals derived from hybridized probes were detected by
LAS-1000 plus (Fujifilm, Tokyo, Japan).
2.5. Reverse transcription-PCR
MBEC4 cells were exposed to normoxia or hypoxia for
6 h. Total RNA (20 Ag) was prepared as described above
and mRNA was purified from total RNA using oligotex-
dT30 hsuperi kit according to the manufacturer’s instruc-
tions. The mRNA was denatured at 70jC for 5 min, chilled
on ice, and added to 50 U RNase inhibitor from human
placenta, 0.5 Ag oligo(dT) primer, 10 mM dithiothreitol, 1
mM dNTPs, 200 U reverse transcriptase and 1 reverse
transcription (RT) buffer (provided with the enzyme) in a
volume of 25 Al, followed by incubation at 50jC for 60
min. The cDNA fragments for the three isoforms of NCX
were amplified by nested PCR. The first PCR was per-
formed using the synthesized first-strand cDNA (1 Al) as a
template, 200 AM dNTPs and 500 nM each of the follow-
ing primers combination in a volume of 50 Al: (a) primers
F11 (5V-CTTCTTCTTTCCCATCTGCGTT-3V; position
808– 829 [29]) and R11 (5V-GACTCTGACATTGC-
TAAGGTGC-3V; position 1591–1570 [29]) for NCX1, (b)
primers F21 (5V-GCCGTAAGATCAAGCACTTAAGGG-
3V; position 566–589 [30]) and R21 (5V-TGCGGTAATC-
CACGTAGAAGGT-3V; position 1297–1276 [30]) for
NCX2, and (c) F31 (5V-AAGAAGACCGCCAGCAT-
GAGTGA-3V; position 1965–1987 [31]) and R31 (5V-
CACCCGATGTCCTCAAAACCTT-3V; position 2505–
2484 [31]) for NCX3. Furthermore, the second PCR was
performed using the first PCR products (1 Al) as a template,
200 AM dNTPs and 500 nM each of the following primers
combination in a volume of 50 Al: (a) primers F12 (5V-
ACATGAAGGAGACAGACCAGCTTC-3V; position 922–
945 [29]) and R12 (5V-CTCTGATTTCCTTCTGGGTCTC-
3V; position 1520–1499 [29]) for NCX1, (b) primers F22
(5V-ACTGCTCACGCTGGTCTTCTTC-3V; position 687–
708 [30]) and R22 (5V-TGGGCTCAAAGAAGA-
TGCGGCT-3V; position 1201–1180 [30]) for NCX2, and
(c) primers F32 (5V-TTTTGACCCATGCTCTTACCAG-3V;
position 2030–2051 [31]) and R32 (5V-CTCTTCTACACG-
GACATTGCTC-3V; position 2306–2285 [31]) for NCX3.
All PCRs were performed using recombinant Taq DNA
polymerase (Toyobo, Osaka, Japan) under the following
conditions: 1 min at 94jC followed by 35 cycles of 1 min
at 94jC, 1.5 min at 55jC and 1.5 min at 72jC, followed
by a single extension of 10 min at 72jC. The PCR
products were cloned into pCR2.1-TOPO vector accord-
ing to the manufacturer’s instructions (Invitrogen) and se-
quenced.
2.6. Preparation of anti-GAPDH and anti-TPI antibodies
Recombinant rat GAPDH and mouse triosephosphate
isomerase (TPI) were used as antigens to prepare anti-
GAPDH and anti-TPI antibodies. Briefly, the expres-
sion vectors of recombinant rat GAPDH and mouse
TPI were constructed using a pET-30 Ek/LIC vector
according to the manufacturer’s instructions (Novagen),
and were named pET/rGAPDH and pET/mTPI.
Recombinant rat GAPDH and mouse TPI, which had
been expressed in pET/rGAPDH- and pET/mTPI-trans-
formed Escherichia coli BL21(DE3) in the presence of
1 mM isopropyl 1-thio-h-D-galactoside, respectively,
were purified using Ni-NTA agarose according to the
manufacturer’s instructions (Qiagen). Anti-rat GAPDH
and anti-mouse TPI antibodies were raised in rabbits
by using each of the affinity-purified proteins, which
had been analyzed to be a single band by SDS-
PAGE.
2.7. Subcellular fractionation and Western blotting
For analysis of GAPDH in the total fraction, MBEC4
cells were exposed to hypoxia for 6 or 12 h. Cells were
washed twice with ice-cold phosphate-buffered saline, pH
7.4, scrapped and harvested by centrifugation at 270 g
for 2 min. These cells were resuspended in buffer A (20
mM Hepes–NaOH, pH 7.5, containing 250 mM sucrose,
1 mM EDTA, 2 mM dithiothreitol, 1 mM AEBSF, 10
Ag/ml leupeptin and 1 Ag/ml aprotinin) and sonicated.
The sonicated cell lysates were used for Western blotting
analysis and for determination of the activity of GAPDH.
On the other hand, to analyze GAPDH in the subcellular
fractions, cells that had been exposed to hypoxia for 12
h were harvested and resuspended in buffer A as
described above, followed by homogenization with 30
strokes of a glass cell homogenizer. The homogenate
was centrifuged at 270 g for 2 min and the supernatant
was transferred to a fresh tube. The pellet was resus-
pended in buffer A, homogenized with the homogenizer
and centrifuged at 270 g for 2 min. The supernatant
obtained was mixed with the first supernatant and
centrifuged at 750 g for 10 min to precipitate the
nuclei. The post-nuclear fraction was further centrifuged
at 105,000 g for 1 h. The final supernatant and
precipitate are referred to as the cytosolic fraction and
particulate fraction, respectively. Nuclei were sonicated in
buffer A, followed by centrifugation at 15,000 g for 10
min. The supernatant obtained is referred to as the
nuclear fraction. Total, cytosolic, nuclear and particulate
fractions (10 Ag of protein) were subjected to SDS-
PAGE in 12.5% gel and transferred to a poly(vinylidene
difluoride) membrane. The membrane was incubated with
anti-GAPDH, anti-TPI or anti-lamin B1 antibodies.
Immunoreactive GAPDH or TPI, and lamin B1 were
further incubated with goat anti-rabbit IgG and goat anti-
mouse IgG, respectively, conjugated to horseradish per-
oxidase, and detected by LAS-1000 plus using Super
Signal Chemiluminescent substrate (Pierce), followed by
quantification.
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2.8. GAPDH activity
Enzyme activity was measured by monitoring the change
in absorbance at 340 nm according to the method of Molina
y Vedia et al. [32].
3. Results
3.1. Inhibition of hypoxia-induced GAPDH mRNA by
BAPTA-AM
Exposure of MBEC4 cells to hypoxia for 6 h substan-
tially increased the level of GAPDH mRNA (Fig. 1). To
assess whether intracellular Ca2 + is involved in the up-
regulation of GAPDH gene expression by hypoxia, MBEC4
cells were exposed to hypoxia in the presence of BAPTA-
AM, an intracellular Ca2 + chelator. The up-regulation of
GAPDH mRNA by hypoxia was inhibited in a dose-
dependent manner by BAPTA-AM, while under normoxic
conditions, BAPTA-AM had no effects on GAPDH gene
expression (Fig. 1). In addition, neither hypoxia nor
BAPTA-AM had any significant effects on the level of
28S rRNA that was used as control. These results suggest
that intracellular Ca2 + contributed to the activation of
GAPDH gene expression in hypoxia.
3.2. Participation of Ca2+ channels in the up-regulation of
GAPDH mRNA by hypoxia
To determine whether Ca2 + channels are involved in
hypoxia-induced GAPDH mRNA expression, MBEC4 cells
were exposed to hypoxia in the presence of each of the Ca2 +
Fig. 2. Effects of Ca2 + channel blockers on up-regulation of GAPDH mRNA by hypoxia. MBEC4 cells were exposed to hypoxia for 6 h in the presence of
LaCl3 (A), bepridil (B), verapamil (C), or nifedipine (D) at a concentration cited. Ca
2 + blockers were added to the medium 1 h before the exposure. Northern
blot analysis of total RNA was performed by GAPDH cDNA and 28S rRNA probes. Data were similar in three experiments.
Fig. 1. Inhibitory effect of BAPTA-AM on induction of GAPDH mRNA by
hypoxia. MBEC4 cells were exposed to hypoxia for 6 h in the presence of
0, 20, 40 or 60 AM BAPTA-AM, which had been added to the medium 1 h
before the exposure. Total RNA was extracted and Northern blot analysis
was performed using probes against GAPDH and 28S rRNA. Similar data
were obtained in three independent experiments.
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channel blockers. When La3 +, a blocker of non-selective
cation channels, was tested, the induction of expression of
GAPDH mRNA by hypoxia was inhibited (Fig. 2A). The
inhibitory effect was dose dependent. Furthermore, bepridil,
a blocker of the Na+/Ca2 + exchanger (NCX), dose-depend-
ently inhibited the hypoxia-induced increase in the GAPDH
mRNA level (Fig. 2B). On the other hand, verapamil and
nifedipine, two L-type Ca2 + channel blockers, had no
significant inhibitory effect on the up-regulation of GAPDH
mRNA by hypoxia (Fig. 2C and D). These results suggest
that the participation of Ca2 + in hypoxia-induced GAPDH
gene expression is through non-selective cation channels
and NCX.
3.3. Existence of mRNAs encoding three isoforms of NCX
Transcripts encoding three NCX isoforms, NCX1, NCX2,
and NCX3, are thought to have unique tissue-specific expres-
sion patterns. To analyze theMBEC4 cell-specific expression
of the NCX isoforms, RT-PCR was performed using specific
primers for each of the NCX isoforms and mRNA from
normoxic or hypoxic cells. As shown in Fig. 3, agarose gel
electrophoresis of the product from RT-PCR using NCX1-
specific primers detected a single band of 599 bp, which is the
exact size predicted from mouse NCX1 [29], in the cells
under both normoxic and hypoxic conditions. Similarly, the
RT-PCRs using NCX2- and NCX3-specific primers combi-
nation resulted in single bands of 515 and 277 bp, which are
the sizes predicted from rat NCX2 [30] and rat NCX3 [31],
respectively, in either the normoxic or hypoxic cells. Each
RT-PCR product was cloned, sequenced, and confirmed to be
the expected NCX isoform. Sequence analyses showed that
the molecular size of each NCX isoform was the same as the
predicted size as described above. These results indicate that
MBEC4 cells expressed mRNAs for the three NCX isoforms
in both normoxia and hypoxia.
3.4. Repression of hypoxia-induced GAPDH mRNA
expression by KN-93 or curcumin
Calmodulin, which is a Ca2 +-binding protein, is a mes-
senger that carries the Ca2 + signal into the nucleus through
the activation of Ca2 +/calmodulin-dependent protein
kinases (CaMKs) [33]. To determine whether CaMKs par-
ticipate in the mechanism by which hypoxia increases
GAPDH mRNA, cells were exposed to hypoxia in the
presence of KN-93, a CaMKs inhibitor. As shown in Fig.
4A, KN-93 abolished the activation of GAPDH gene
expression by hypoxia. The inhibition by KN-93 was dose
dependent. CaMKs have been reported to contribute to the
activation of the c-fos promoter by hypoxia [34]. A protein
complex composed of c-Fos and c-Jun, which are the
translational products of the protooncogenes c-fos and c-
jun, respectively, binds to the AP-1 element [35]. To assess
whether c-jun gene expression controls the up-regulation of
GAPDH gene expression in hypoxia, cells were exposed to
hypoxia in the presence of curcumin, an inhibitor of c-jun
gene expression. As shown in Fig. 4B, curcumin suppressed
the activation of GAPDH gene expression by hypoxia in a
Fig. 3. Expression of NCX isoform mRNAs in MBEC4 cells. MBEC4 cells
were exposed to normoxia (N) or hypoxia (H) for 6 h. The RT reaction was
performed using mRNAs. The RT products were amplified by nested PCRs
using NCX isoform-specific primers. The PCR products (10 Al) were
subjected to agarose gel electrophoresis, followed by detection using
ethidium bromide. For estimation of molecular mass, fX174 fragments
digested with HaeIII were used as a DNA marker (M).
Fig. 4. Inhibitory effect of KN-93 or curcumin on hypoxia-induced
GAPDH mRNA expression. MBEC4 cells were exposed to hypoxia for 6 h
in the presence of 0, 10, 30 or 50 AM KN-93, or 0, 10, 30 or 50 AM
curcumin, which had been added to the medium 1 h before the exposure.
Total RNA was extracted and analyzed by Northern blot using probes
against GAPDH and 28S rRNA. Similar data were observed in three
experiments.
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dose-dependent manner. These results suggest that hypoxia
up-regulated GAPDH gene expression through the AP-1
element.
3.5. GAPDH proteins and activities in subcellular fractions
under hypoxic conditions
MBEC4 cells were exposed to hypoxia for 6 or 12 h, and
the cell lysates were subjected to SDS-PAGE, followed by
Western blotting with anti-GAPDH antibodies. As shown in
Fig. 5A, 6 and 12 h of hypoxia resulted in 2.2- and 4-fold
increases in the levels of GAPDH protein in the total
fraction, respectively, compared with normoxia. However,
the activities of GAPDH under hypoxic conditions did not
increase in the same proportions as GAPDH protein. To
determine the intracellular distribution of hypoxia-induced
GAPDH, cells were exposed to hypoxia for 12 h and
homogenized, and the cytosolic, nuclear and particulate
fractions were separated by differential centrifugation. Pro-
teins were subjected to SDS-PAGE and transferred to a
membrane. Western blot analyses with anti-GAPDH anti-
bodies indicated that GAPDH protein levels in the cytosolic,
nuclear and particulate fractions of hypoxic cells were
elevated 4.0-, 2.3- and 4.2-fold, respectively, compared with
those in normoxic cells (Fig. 5B). TPI, a cytosolic marker
protein, and lamin B1, a nuclear marker protein, were
detected only in each corresponding fraction. Glycolytic
GAPDH activities were detected in the cytosolic, nuclear
and particulate fractions. On the other hand, the relative
GAPDH activities of hypoxic cells to normoxic cells in
these fractions were 1.4-, 1.3-, and 1.6-fold, respectively.
This indicates that the increase of GAPDH proteins was
lower than the increase of GAPDH activities, even in the
hypoxic cytosolic fraction.
4. Discussion
Changes in the cellular environment allow mammalian
cells to express specific stress proteins to maintain homeo-
stasis. As a universal cellular response mechanism to
hypoxia, cells induce the expression of glycolytic enzymes
and shift the primary biosynthetic pathway of ATP from
oxidative phosphorylation to glycolysis [3–5]. Furthermore,
hypoxia increases intracellular Ca2 + concentration by
increasing Ca2 + influx from extracellular space or by
releasing Ca2 + from intracellular Ca2 + stores [21–26].
The rise of intracellular Ca2 + concentration can influence
a variety of biochemical processes including transcriptional
regulation of gene expression [36]. Although GAPDH gene
has been thought to be one of the housekeeping genes,
recent evidence demonstrates that GAPDH gene expression
is up-regulated by hypoxia in certain types of cells such as
endothelial cells and alveolar epithelial cells [15,37]. In the
present study, the involvement of intracellular Ca2 + in the
pathway transmitting the hypoxic stimulus to GAPDH gene
Fig. 5. GAPDH proteins and activities in subcellular fractions in hypoxia.
(A) MBEC4 cells were exposed to normoxia (N) or hypoxia (H) for 6 or 12 h
and harvested. The sonicated cell lysates were prepared as total fraction,
and samples (10 Ag protein) were subjected to SDS-PAGE and
immunoreacted on Western blot with anti-GAPDH antibody, followed by
detection with chemiluminescent substrate and quantification using
densitometry. The amount of GAPDH protein and the level of GAPDH
activity in the hypoxic cells were expressed as multiples of the values in the
normoxic cells (meanF S.E.). GAPDH activities determined in the 6- and
12-h normoxic cells were 966F 10 and 985F 21 nmol/min/mg protein,
respectively. (B) Cells were exposed to hypoxia for 12 h and harvested,
followed by homogenization. The homogenates were fractionated by
centrifugation and subcellular fractions were prepared. Equal amounts of
protein (10 Ag) from each subcellular fraction were subjected to SDS-
PAGE, followed by Western blotting with anti-GAPDH, anti-TPI or anti-
lamin B1 antibody. Immunoreactive bands were detected using chemilu-
minescent substrate, followed by quantification using densitometry.
GAPDH protein and GAPDH activity in each fraction of the hypoxic cells
were expressed as described above. GAPDH activities in the cytosolic,
nuclear and particulate fractions of the normoxic cells were 2350F 80,
281F 21.2 and 154F 8.0 nmol/min/mg protein, respectively. Experiments
were replicated three times.
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activation in MBEC4 cells was estimated by using pharma-
cological reagents.
Data obtained by using BAPTA-AM suggest that intra-
cellular Ca2 + contributes to the increase in the transcrip-
tional level of GAPDH in MBEC4 cells exposed to hypoxia
(Fig. 1). In addition, the hypoxia-induced up-regulation of
GAPDH expression was inhibited by a blocker for non-
selective cation channels or NCX (Fig. 2). In the normal
state, non-selective cation channels and NCX regulate the
primary Ca2 + influx and efflux mechanisms, respectively;
however, the net direction in which NCX transports Ca2 +
can be reversed in response to changes in physiological
conditions [38]. It is thus reasonable to postulate that NCX,
in addition to non-selective cation channels, participates in
the influx of Ca2 + from the extracellular space to increase
the intracellular Ca2 + concentration when MBEC4 cells are
exposed to hypoxia, and the increase in the Ca2 + concen-
tration is crucial for the hypoxia-induced transcriptional
activation of the GAPDH gene.
NCX has been found to have three isoforms, NCX1,
NCX2 and NCX3 [29–31,39]. The mRNAs for the three
NCX isoforms are thought to have unique tissue-specific
expression patterns. NCX1 and NCX2 mRNAs are ubiqui-
tously expressed in many tissues, suggesting that NCX1 and
NCX2 function in a broader range of tissues. On the other
hand, NCX3 mRNA is distributed in a narrower range of
tissues, in particular, brain and skeletal muscle. Rat thoracic
aortic endothelial cells express NCX1 and NCX2 mRNAs,
but not NCX3 mRNA [39], whereas MBEC4 cells expressed
not only NCX1 and NCX2 mRNAs, but also NCX3 mRNA
(Fig. 3). Although the overall functional properties of the
three NCX isoforms are fundamentally similar, depletion of
cellular ATP inhibits NCX1 and NCX2 activities, but not
NCX3 activity [40]. In MBEC4 cells under hypoxic con-
ditions, in which cellular ATP production is decreased,
NCX3 is expected to play an important role in the regulation
of cytosolic Ca2 +. These results suggest that hypoxia accel-
erates Ca2 + influx through non-selective cation channels and
causes the three isoforms of NCX to operate in reverse.
It has been reported that hypoxia stimulates Ca2 + influx
from the extracellular space through L-type Ca2 + channels
in PC12 cells, leading to the up-regulation of tyrosine
hydroxylase and c-fos mRNAs [24,34]. However, in
MBEC4 cells, L-type Ca2 + channel blockers (nifedipine
and verapamil) did not affect the hypoxia-induced increase
in GAPDH mRNA (Fig. 2). A similar result was reported in
bovine aortic and pulmonary artery endothelial cells [41].
L-type Ca2 + channels do not seem to be necessary for
regulating intracellular Ca2 + concentration in response to
hypoxia in endothelial cells.
We used KN-93 and curcumin to analyze downstream
pathways activated by the rise in intracellular Ca2 + con-
centration in response to hypoxia. Both KN-93 and curcu-
min abolished the induction of GAPDH gene expression by
hypoxia (Fig. 4). Ca2 + regulates c-fos gene expression in
response to various stimuli through the activation of
CaMKs [34], and hypoxia results in the induction of c-
jun gene expression in endothelial cells [42]. A heterodimer
of c-Fos and c-Jun makes up the AP-1 complex [35],
implying that AP-1 participates in the transcriptional acti-
vation of the GAPDH gene by hypoxia. Furthermore, the
human GAPDH gene possesses a HIF-1 binding site, which
requires for the flanking sequence to be functionally active
[20]. The transcription of VEGF and tyrosine hydroxylase
genes is up-regulated by the binding of both HIF-1 and AP-
1 to each consensus enhancer sequence in hypoxia [43,44].
This suggests that both AP-1 and HIF-1 participate in the
hypoxia-activated gene expression in GAPDH as well as in
VEGF and tyrosine hydroxylase. There are some candi-
dates for AP-1 element on the 5V-flanking region of the
human GAPDH gene ( 2474 to  2467,  1845 to
 1839,  1592 to  1586 and  1062 to  1056). Our
preliminary studies suggest that the region located at
 1091 to  1053 is not involved in the induction of
human GAPDH gene expression by hypoxia (data not
shown). We are now studying the involvement of other
candidates.
In bovine aortic endothelial cells, hypoxia primarily
induces the cytosolic GAPDH and only slightly induces
the nuclear GAPDH [15]. In MBEC4 cells, the hypoxia-
induced increase of GAPDH protein was observed in the
particulate fraction, in addition to the cytosolic and nuclear
fractions, and the extent of the increase in the particulate
fraction was comparable to that in the cytosolic fraction
(Fig. 5). However, even in the cytosol, the increased
GAPDH activity did not correlate with the increase in
GAPDH protein. In the nuclear and particulate fractions,
GAPDH is not needed for glycolysis. However, in these
fractions, GAPDH has been found to possess several non-
glycolytic functions such as DNA repair, DNA replication,
nuclear tRNA export, tubulin polymerization, endocytosis,
apoptosis, translational regulation of gene expression and
vesicular transport in the early secretory pathway [16–19].
Our present data taken together with the results of previous
reports suggest that, in MBEC4 cells, GAPDH is induced by
hypoxia not only to compensate for a reduced ATP by
accelerating turnover rate of cytosolic glycolysis, but also to
participate in certain functions unassociated with glycolytic
activity in the nuclear and particulate fractions, and prob-
ably even in the cytosolic fraction.
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